Prevention of chronic allograft rejection by Vitamin D receptor agonists

Immunology Letters

Volumn 100, Issue 1, 2005, Pages 34-41

  Adorini, Luciano ^a   Amuchastegui, Susana ^a   Daniel, Kenn C ^a  

^a BioXell SpA   (Italy)

Author keywords

Chronic allograft rejection; Immunomodulation; Vitamin D receptor agonists

Indexed keywords

20 EPICALCITRIOL; 22 OXACALCITRIOL; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BXL 628; CALCINEURIN INHIBITOR; CALCITRIOL; CYCLOSPORIN A; DEXAMETHASONE; GLUCOCORTICOID; PARTIAL AGONIST; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

AGONIST; ANTINEOPLASTIC ACTIVITY; BONE METABOLISM; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; GRAFT SURVIVAL; HUMAN; IMMUNOREGULATION; LEUKOCYTE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; RECEPTORS, CALCITRIOL; SECOSTEROIDS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 24344440277     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.06.017     Document Type: Review

References (81)

1. P. Libby, and J.S. Pober Chronic rejection Immunity 14 2001 387 397
2. M.P. Hernandez-Fuentes, and R.I. Lechler Chronic graft loss. Immunological and non-immunological factors Contrib Nephrol 146 2005 54 64
3. M. Pascual, T. Theruvath, T. Kawai, N. Tolkoff-Rubin, and A.B. Cosimi Strategies to improve long-term outcomes after renal transplantation N Engl J Med 346 2002 580 590
4. T. Fehr, and M. Sykes Tolerance induction in clinical transplantation Transpl Immunol 13 2004 117 130
5. H.F. Deluca, and M.T. Cantorna Vitamin D: its role and uses in immunology Faseb J 15 2001 2579 2585
6. C. Mathieu, and L. Adorini The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents Trends Mol Med 8 2002 174 179
7. M.D. Griffin, N. Xing, and R. Kumar Vitamin D and its analogs as regulators of immune activation and antigen presentation Annu Rev Nutr 2003
8. K.V. Pinette, Y.K. Yee, B.Y. Amegadzie, and S. Nagpal Vitamin D receptor as a drug discovery target Mini Rev Med Chem 3 2003 193 204
9. S. Nagpal, S. Na, and R. Rathnachalam Non-calcemic actions of Vitamin D receptor ligands Endocr Rev 2005
10. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, S.H. Selznick, C.E. Dominguez, and P.W. Jurutka The nuclear Vitamin D receptor: biological and molecular regulatory properties revealed J Bone Miner Res 13 1998 325 349
11. C. Carlberg Current understanding of the function of the nuclear Vitamin D receptor in response to its natural and synthetic ligands Recent Results Cancer Res 164 2003 29 42
12. A.S. Dusso, R. Thadhani, and E. Slatopolsky Vitamin D receptor and analogs Semin Nephrol 24 2004 10 16
13. K. Fogh, and K. Kragballe New Vitamin D analogs in psoriasis Curr Drug Targets Inflamm Allergy 3 2004 199 204
14. L. Adorini Immunomodulatory effects of Vitamin D receptor ligands in autoimmune diseases Int Immunopharmacol 2 2002 1017 1028
15. L. Adorini 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation Curr Opin Investig Drugs 3 2002 1458 1463
16. B.N. Becker, D.A. Hullett, J.K. O'Herrin, G. Malin, H.W. Sollinger, and H. DeLuca Vitamin D as immunomodulatory therapy for kidney transplantation Transplantation 74 2002 1204 1206
17. N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz, and D. Moras The crystal structure of the nuclear receptor for Vitamin D bound to its natural ligand Mol Cell 5 2000 173 179
18. G. Tocchini-Valentini, N. Rochel, J.M. Wurtz, and D. Moras Crystal structures of the Vitamin D nuclear receptor liganded with the Vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification J Med Chem 47 2004 1956 1961
19. D.M. Provvedini, C.D. Tsoukas, L.J. Deftos, and S.C. Manolagas 1,25-dihydroxyvitamin D3 receptors in human leukocytes Science 221 1983 1181 1183
20. A.K. Bhalla, E.P. Amento, B. Serog, and L.H. Glimcher 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation J Immunol 133 1984 1748 1754
21. J.M. Lemire, D.C. Archer, L. Beck, and H.L. Spiegelberg Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions J Nutr 125 1995 1704S 1708S
22. 3 Eur J Immunol 30 2000 498 508
23. 3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor Mol Cell Biol 15 1995 5789 5799
24. 3-mediated effects J Immunol 160 1998 209 218
25. 3: a transcriptional modulator of the IFN-g gene Eur J Immunol 28 1998 3017 3030
26. + T cells to enhance the development of Th2 cells J Immunol 167 2001 4974 4980
27. L. Adorini, N. Giarratana, and G. Penna Pharmacological induction of tolerogenic dendritic cells and regulatory T cells Semin Immunol 16 2004 127 134
28. G. Penna, and L. Adorini 1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation J Immunol 164 2000 2405 2411
29. L. Piemonti, P. Monti, M. Sironi, P. Fraticelli, B.E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells J Immunol 164 2000 4443 4451
30. M.D. Griffin, W.H. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Potent inhibition of dendritic cell differentiation and maturation by Vitamin D analogs Biochem Biophys Res Commun 270 2000 701 708
31. A. Berer, J. Stockl, O. Majdic, T. Wagner, M. Kollars, K. Lechner, K. Geissler, and L. Oehler 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro Exp Hematol 28 2000 575 583
32. M.O. Canning, K. Grotenhuis, H. de Wit, C. Ruwhof, and H.A. Drexhage 1-alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes Eur J Endocrinol 145 2001 351 357
33. A.G. van Halteren, E. van Etten, E.C. de Jong, R. Bouillon, B.O. Roep, and C. Mathieu Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3) Diabetes 51 2002 2119 2125
34. M.C. Gauzzi, C. Purificato, K. Donato, Y. Jin, L. Wang, K.C. Daniel, A.A. Maghazachi, F. Belardelli, L. Adorini, and S. Gessani Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis J Immunol 174 2005 270 276
35. M.C. Gauzzi, C. Purificato, L. Conti, L. Adorini, F. Belardelli, and S. Gessani IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1{alpha},25-dihydroxyvitamin D3 J Leukoc Biol 2005
36. L. Adorini, G. Penna, N. Giarratana, and M. Uskokovic Tolerogenic dendritic cells induced by Vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases J Cell Biochem 88 2003 227 233
37. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 2002 725 734
38. J. Cadranel, M. Garabedian, B. Milleron, H. Guillozo, G. Akoun, and A.J. Hance 1,25(OH)2D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis J Clin Invest 85 1990 1588 1593
39. M. Hewison, L. Freeman, S.V. Hughes, K.N. Evans, R. Bland, A.G. Eliopoulos, M.D. Kilby, P.A. Moss, and R. Chakraverty Differential regulation of Vitamin D receptor and its ligand in human monocyte-derived dendritic cells J Immunol 170 2003 5382 5390
40. M.D. Griffin, W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean, and R. Kumar Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a Vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc Natl Acad Sci USA 22 2001 22
41. J.M. Lemire, D.C. Archer, A. Khulkarni, A. Ince, M.R. Uskokovic, and S. Stepkowski Prolongation of the survival of murine cardiac allografts by the Vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol Transplantation 54 1992 762 763
42. C. Johnsson, and G. Tufveson MC1288-a Vitamin D analogue with immunosuppressive effects on heart and small bowel grafts Transpl Int 7 1994 392 397
43. D.A. Hullett, M.T. Cantorna, C. Redaelli, J. Humpal-Winter, C.E. Hayes, H.W. Sollinger, and H.F. Deluca Prolongation of allograft survival by 1,25-dihydroxyvitamin D3 Transplantation 66 1998 824 828
44. S. Amuchastegui, K.C. Daniel, and L. Adorini Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist Transplantation 2005 80
45. E. Kallio, P. Hayry, and S. Pakkala MC1288, a Vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat Transplant Proc 28 1996 3113
46. C.A. Redaelli, M. Wagner, D. Gunter-Duwe, Y.H. Tian, P.F. Stahel, L. Mazzucchelli, R.A. Schmid, and M.K. Schilling 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants Kidney Int 61 2002 288 296
47. C.A. Redaelli, M. Wagner, Y.H. Tien, L. Mazzucchelli, P.F. Stahel, M.K. Schilling, and J.F. Dufour 1alpha,25-dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts Hepatology 34 2001 926 934
48. A.B. Zhang, S.S. Zheng, C.K. Jia, and Y. Wang Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation World J Gastroenterol 9 2003 1067 1071
49. S. Gregori, M. Casorati, S. Amuchastegui, S. Smiroldo, A.M. Davalli, and L. Adorini Regulatory T cells induced by 1a,25-Dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance J Immunol 167 2001 1945 1953
50. K.M. Casteels, C. Mathieu, M. Waer, D. Valckx, L. Overbergh, J.M. Laureys, and R. Bouillon Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A Endocrinology 139 1998 95 102
51. E. van Etten, C. Gysemans, A. Verstuyf, R. Bouillon, and C. Mathieu Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation Transplant Proc 33 2001 2319
52. C. Gysemans, M. Waer, J. Laureys, R. Bouillon, and C. Mathieu A combination of KH1060, a Vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice Transplant Proc 33 2001 2365
53. P. Veyron, R. Pamphile, L. Binderup, and J.L. Touraine Two novel Vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice Transpl Immunol 1 1993 72 76
54. J. Merke, W. Hofmann, D. Goldschmidt, and E. Ritz Demonstration of 1,25(OH)2 Vitamin D3 receptors and actions in vascular smooth muscle cells in vitro Calcif Tissue Int 41 1987 112 114
55. M.E. DeVries, K.A. Hosiawa, C.M. Cameron, S.E. Bosinger, D. Persad, A.A. Kelvin, J.C. Coombs, H. Wang, R. Zhong, M.J. Cameron, and D.J. Kelvin The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury Semin Immunol 15 2003 33 48
56. W.W. Hancock, L. Wang, Q. Ye, R. Han, and I. Lee Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression Curr Opin Immunol 15 2003 479 486
57. N. Giarratana, G. Penna, S. Amuchastegui, R. Mariani, K.C. Daniel, and L. Adorini A Vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development J Immunol 173 2004 2280 2287
58. W.W. Hancock, B. Lu, W. Gao, V. Csizmadia, K. Faia, J.A. King, S.T. Smiley, M. Ling, N.P. Gerard, and C. Gerard Requirement of the chemokine receptor CXCR3 for acute allograft rejection J Exp Med 192 2000 1515 1520
59. M. Rotondi, A. Rosati, A. Buonamano, L. Lasagni, E. Lazzeri, F. Pradella, V. Fossombroni, C. Cirami, F. Liotta, G. La Villa, M. Serio, E. Bertoni, M. Salvadori, and P. Romagnani High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure Am J Transplant 4 2004 1466 1474
60. J.J. Yun, M.P. Fischbein, D. Whiting, Y. Irie, M.C. Fishbein, M.D. Burdick, J. Belperio, R.M. Strieter, H. Laks, J.A. Berliner, and A. Ardehali The role of MIG/CXCL9 in cardiac allograft vasculopathy Am J Pathol 161 2002 1307 1313
61. G. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1a,25-Dihydroxyvitamin D3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice Diabetes 51 2002 1367 1374
62. K.J. Wood, S. Sakaguchi, and Regulatory T cells in transplantation tolerance Nat Rev Immunol 3 2003 199 210
63. H. Hackstein, and A.W. Thomson Dendritic cells: emerging pharmacological targets of immunosuppressive drugs Nat Rev Immunol 4 2004 24 34
64. J.K. Aschenbrenner, H.W. Sollinger, B.N. Becker, and D.A. Hullett 1,25-OH(2)D(3) alters the transforming growth factor beta signaling pathway in renal tissue J Surg Res 100 2001 171 175
65. A.K. Raisanen-Sokolowski, I.S. Pakkala, S.P. Samila, L. Binderup, P.J. Hayry, and S.T. Pakkala A Vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts Transplantation 63 1997 936 941
66. M. Demay Muscle: a nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent Vitamin D receptor actions Endocrinology 144 2003 5135 5137
67. I. Endo, D. Inoue, T. Mitsui, Y. Umaki, M. Akaike, T. Yoshizawa, S. Kato, and T. Matsumoto Deletion of Vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors Endocrinology 144 2003 5138 5144
68. C. Crescioli, A. Morelli, L. Adorini, P. Ferruzzi, M. Luconi, G. Barbara Vannelli, M. Marini, S. Gelmini, B. Fibbi, S. Donati, D. Villari, G. Forti, E. Colli, K.E. Andersson, and M. Maggi Human bladder as a novel target for Vitamin D receptor ligands J Clin Endocrinol Metab 2004
69. J.B. Lazaro, P.J. Bailey, and A.B. Lassar Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation Genes Dev 16 2002 1792 1805
70. C. Buitrago, R. Boland, and A.R. de Boland The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells Biochim Biophys Acta 1541 2001 179 187
71. E. van Etten, D.D. Branisteanu, A. Verstuyf, M. Waer, R. Bouillon, and C. Mathieu Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants Transplantation 69 2000 1932 1942
72. J.K. O'Herrin, D.A. Hullett, D.M. Heisey, H.W. Sollinger, and B.N. Becker A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function Am J Nephrol 22 2002 515 520
73. N. Tanaci, H. Karakose, N. Guvener, N.B. Tutuncu, T. Colak, and M. Haberal Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study Transplant Proc 35 2003 2885 2887
74. H.U. Stempfle, C. Werner, U. Siebert, T. Assum, U. Wehr, W.A. Rambeck, B. Meiser, K. Theisen, and R. Gartner The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol Transplantation 73 2002 547 552
75. V.M. Brandenburg, R. Westenfeld, and M. Ketteler The fate of bone after renal transplantation J Nephrol 17 2004 190 204
76. L. Merida, M. Shigetomi, K. Ihara, T. Tsubone, K. Ikeda, A. Yamaguchi, T. Sugiyama, and S. Kawai Effects of Vitamin D analog, 22-oxa-1,25- dihydroxyvitamin D(3), on bone reconstruction by vascularized bone allograft Bone 30 2002 422 427
77. M.T. Cantorna, D.A. Hullett, C. Redaelli, C.R. Brandt, J. Humpal-Winter, H.W. Sollinger, and H.F. Deluca 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density Transplantation 66 1998 828 831
78. T.T. Wang, F.P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J.H. Hanrahan, S. Mader, and J.H. White Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression J Immunol 173 2004 2909 2912
79. J. Trofe, T.M. Beebe, J.F. Buell, M.J. Hanaway, M.R. First, R.R. Alloway, T.G. Gross, and E.S. Woodle Posttransplant malignancy Prog Transplant 14 2004 193 200
80. I. Pakkala, E. Taskinen, S. Pakkala, and A. Raisanen-Sokolowski MC1288, a Vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation Bone Marrow Transplant 27 2001 863 867
81. K. Casteels, M. Waer, J. Laureys, D. Valckx, J. Depovere, R. Bouillon, and C. Mathieu Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a Vitamin D3 analog and cyclosporine Transplantation 65 1998 1225 1232